Clinical TrialsSearch results
Number of results: 918
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase II study of rituximab in patients with severe systemic lupus erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-03-16
Other
- A multicenter phase II open-label study in untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma evaluating efficacy and safety of maintenance therapy with IDEC-C2B8.
- Untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma.
- Zenyaku Kogyo Co., Ltd.
- 2008-12-26
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Recruiting
- A MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-BLIND PHASE III CLINICAL TRIAL OF OBINUTUZUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- systemic lupus erythematosus
- Yoshiya Tanaka
- 2023-06-25
Other
- Safety of Early Exercise Training in Patients Underwent Elective Coronary Stenting
- stable angina
- Yoshimitsu Soga
- 2009-05-10
Completed
- Effects of microbiome from probiotics and fermented foods on the pharmacokinetics of orally administered drugs
- healthy male
- Yoshihara Tatsuya
- 2023-08-28
Recruiting
- Dynamic assessment of elderly cancer patients
- Cancer
- Yoshida Yoichiro
- 2022-02-01
Completed
- Clinical Pharmacology Study of KC-8025 in Japanese and Caucasian healthy adults (Phase I).
- Japanese and Caucasian healthy adult participants
- Yonemura Takuma
- 2023-12-15
Completed
- Bioequivalence study of FKB327 and adalimumab in healthy adult male subjects
- Rheumatoid arthritis
- Yonemura Takuma
- 2020-11-25